1. Home
  2. CLBK vs TNGX Comparison

CLBK vs TNGX Comparison

Compare CLBK & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

HOLD

Current Price

$18.16

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$12.34

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBK
TNGX
Founded
1927
2014
Country
US
US
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CLBK
TNGX
Price
$18.16
$12.34
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$17.00
$14.33
AVG Volume (30 Days)
251.6K
2.4M
Earning Date
05-04-2026
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.35
N/A
Revenue
N/A
$42,069,000.00
Revenue This Year
$3.97
$52.63
Revenue Next Year
$11.43
N/A
P/E Ratio
$35.82
N/A
Revenue Growth
N/A
15.17
52 Week Low
$12.64
$1.04
52 Week High
$18.87
$13.48

Technical Indicators

Market Signals
Indicator
CLBK
TNGX
Relative Strength Index (RSI) 62.04 54.92
Support Level $17.82 $12.12
Resistance Level $18.67 $13.18
Average True Range (ATR) 0.62 0.74
MACD 0.03 -0.08
Stochastic Oscillator 73.93 52.16

Price Performance

Historical Comparison
CLBK
TNGX

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: